Valuation: Photonstar Led Group PLC

Market Cap 5.71K 5.01K 4.73K 4.31K 8.07K 547K 8.13K 56.6K 21.92K 279K 21.43K 20.96K 898K P/E 2019
-0.01x
P/E 2020 -0.02x
Enterprise Value -78.29K -68.7K -64.89K -59.13K -111K -7.5M -111K -776K -301K -3.83M -294K -288K -12.32M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
76.48%
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Director of Finance/CFO 65 13/05/2021
Chief Tech/Sci/R&D Officer 61 01/01/2025
Director TitleAgeSince
Director/Board Member 45 28/01/2019
Chairman 70 20/05/2019
Director/Board Member 61 13/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-99.07% - - 3.54M
+3.22%+5.43%-4.43%+93.21% 9.5B
-5.66%-3.69%+271.06%+262.69% 2.47B
+0.58%+3.95%-31.72%-37.89% 2.1B
-0.41%+0.27%-15.36%-30.08% 1.61B
+2.94%+18.50%+136.73% - 1.2B
+4.01%+16.27%+94.09%+80.59% 1.04B
-0.20%-0.20%-23.08%-11.23% 976M
+0.72%+3.64%-10.90%+34.42% 763M
-0.39%-4.89%+14.49%+110.09% 744M
Average +0.48%+4.31%+47.88%+62.72% 2.27B
Weighted average by Cap. +1.22%+4.36%+38.14%+82.65%

Financials

2019 2020
Net sales - -
Net income -832K -730K -690K -628K -1.18M -79.74M -1.18M -8.25M -3.2M -40.74M -3.12M -3.06M -131M -306K -269K -254K -231K -433K -29.33M -436K -3.03M -1.18M -14.98M -1.15M -1.12M -48.15M
Net Debt -378K -332K -313K -285K -534K -36.23M -538K -3.75M -1.45M -18.51M -1.42M -1.39M -59.49M -84K -73.71K -69.62K -63.44K -119K -8.05M -120K -833K -323K -4.11M -315K -309K -13.22M
Logo Photonstar Led Group PLC
Cizzle Biotechnology Holdings PLC is a United Kingdom-based diagnostics developer of early cancer tests. The Company is focused on early detection of lung cancer via the development of an immunoassay test for the CIZ1B biomarker. CIZ1B is a variant of CIZ1, a naturally occurring cell nuclear protein involved in protecting deoxyribonucleic acid (DNA). Its CIZ1B biomarker detects lung cancer at its earliest and most treatable stage. It is designed as a simple blood test, which enables early diagnosis before symptoms appear-when treatment options can transform outcomes for patients and families.
Employees
-